Regeneron pharmaceuticals, inc. (regn) investigation: bronstein, gewirtz & grossman, llc encourages investors to seek compensation for alleged wrongdoings

New york, ny / accesswire / june 2, 2024 / bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of regeneron pharmaceuticals, inc. ("regeneron" or "the company") (nasdaq:regn). investors who purchased regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/regn.
REGN Ratings Summary
REGN Quant Ranking